Safety and efficacy of a low-dose combination of midazolam, alfentanil, and propofol for deep sedation of elderly patients undergoing ERCP

Abstract Background Proper sedation of patients, particularly elderly individuals, who are more susceptible to sedation-related complications, is of significant importance in endoscopic retrograde cholangiopancreatography (ERCP). This study aims to assess the safety and efficacy of a low-dose combin...

Full description

Bibliographic Details
Published in:BMC Gastroenterology
Main Authors: Yanping Zhang, Ning Zhang, Jing Hu, Changlin Liu, Guanjun Li
Format: Article
Language:English
Published: BMC 2024-04-01
Subjects:
Online Access:https://doi.org/10.1186/s12876-024-03197-9
_version_ 1850322963398656000
author Yanping Zhang
Ning Zhang
Jing Hu
Changlin Liu
Guanjun Li
author_facet Yanping Zhang
Ning Zhang
Jing Hu
Changlin Liu
Guanjun Li
author_sort Yanping Zhang
collection DOAJ
container_title BMC Gastroenterology
description Abstract Background Proper sedation of patients, particularly elderly individuals, who are more susceptible to sedation-related complications, is of significant importance in endoscopic retrograde cholangiopancreatography (ERCP). This study aims to assess the safety and efficacy of a low-dose combination of midazolam, alfentanil, and propofol for deep sedation in elderly patients undergoing ERCP, compared to a group of middle-aged patients. Methods The medical records of 610 patients with common bile duct stones who underwent elective ERCP under deep sedation with a three-drug regimen, including midazolam, alfentanil, and propofol at Shandong Provincial Third Hospital from January 2023 to September 2023 were retrospectively reviewed in this study. Patients were categorized into three groups: middle-aged (50–64 years, n = 202), elderly (65–79 years, n = 216), and very elderly (≥ 80 years, n = 192). Intraoperative vital signs and complications were compared among these groups. Results The three groups showed no significant difference in terms of intraoperative variation of systolic blood pressure (P = 0.291), diastolic blood pressure (P = 0.737), heart rate (P = 0.107), peripheral oxygen saturation (P = 0.188), bispectral index (P = 0.158), and the occurrence of sedation-related adverse events including hypotension (P = 0.170) and hypoxemia (P = 0.423). Conclusion The results suggest that a low-dose three-drug regimen consisting of midazolam, alfentanil, and propofol seems safe and effective for deep sedation of elderly and very elderly patients undergoing ERCP procedures. However, further studies are required to verify these findings and clarify the benefits and risks of this method.
format Article
id doaj-art-6b2d4e6faada422fa48df83203fda9b2
institution Directory of Open Access Journals
issn 1471-230X
language English
publishDate 2024-04-01
publisher BMC
record_format Article
spelling doaj-art-6b2d4e6faada422fa48df83203fda9b22025-08-19T23:21:47ZengBMCBMC Gastroenterology1471-230X2024-04-012411810.1186/s12876-024-03197-9Safety and efficacy of a low-dose combination of midazolam, alfentanil, and propofol for deep sedation of elderly patients undergoing ERCPYanping Zhang0Ning Zhang1Jing Hu2Changlin Liu3Guanjun Li4Department of Anesthesiology, Cheeloo College of Medicine, Shandong Provincial Third Hospital, Shandong UniversityDepartment of Cardiopulmonary rehabilitation, Cheeloo College of Medicine, Shandong Provincial Third Hospital, Shandong UniversityDepartment of Anesthesiology, Cheeloo College of Medicine, Shandong Provincial Third Hospital, Shandong UniversityDepartment of Anesthesiology, Cheeloo College of Medicine, Shandong Provincial Third Hospital, Shandong UniversityDepartment of Anesthesiology, Cheeloo College of Medicine, Shandong Provincial Third Hospital, Shandong UniversityAbstract Background Proper sedation of patients, particularly elderly individuals, who are more susceptible to sedation-related complications, is of significant importance in endoscopic retrograde cholangiopancreatography (ERCP). This study aims to assess the safety and efficacy of a low-dose combination of midazolam, alfentanil, and propofol for deep sedation in elderly patients undergoing ERCP, compared to a group of middle-aged patients. Methods The medical records of 610 patients with common bile duct stones who underwent elective ERCP under deep sedation with a three-drug regimen, including midazolam, alfentanil, and propofol at Shandong Provincial Third Hospital from January 2023 to September 2023 were retrospectively reviewed in this study. Patients were categorized into three groups: middle-aged (50–64 years, n = 202), elderly (65–79 years, n = 216), and very elderly (≥ 80 years, n = 192). Intraoperative vital signs and complications were compared among these groups. Results The three groups showed no significant difference in terms of intraoperative variation of systolic blood pressure (P = 0.291), diastolic blood pressure (P = 0.737), heart rate (P = 0.107), peripheral oxygen saturation (P = 0.188), bispectral index (P = 0.158), and the occurrence of sedation-related adverse events including hypotension (P = 0.170) and hypoxemia (P = 0.423). Conclusion The results suggest that a low-dose three-drug regimen consisting of midazolam, alfentanil, and propofol seems safe and effective for deep sedation of elderly and very elderly patients undergoing ERCP procedures. However, further studies are required to verify these findings and clarify the benefits and risks of this method.https://doi.org/10.1186/s12876-024-03197-9Endoscopic retrograde cholangiopancreatographyElderlyDeep sedationMidazolamAlfentanilPropofol
spellingShingle Yanping Zhang
Ning Zhang
Jing Hu
Changlin Liu
Guanjun Li
Safety and efficacy of a low-dose combination of midazolam, alfentanil, and propofol for deep sedation of elderly patients undergoing ERCP
Endoscopic retrograde cholangiopancreatography
Elderly
Deep sedation
Midazolam
Alfentanil
Propofol
title Safety and efficacy of a low-dose combination of midazolam, alfentanil, and propofol for deep sedation of elderly patients undergoing ERCP
title_full Safety and efficacy of a low-dose combination of midazolam, alfentanil, and propofol for deep sedation of elderly patients undergoing ERCP
title_fullStr Safety and efficacy of a low-dose combination of midazolam, alfentanil, and propofol for deep sedation of elderly patients undergoing ERCP
title_full_unstemmed Safety and efficacy of a low-dose combination of midazolam, alfentanil, and propofol for deep sedation of elderly patients undergoing ERCP
title_short Safety and efficacy of a low-dose combination of midazolam, alfentanil, and propofol for deep sedation of elderly patients undergoing ERCP
title_sort safety and efficacy of a low dose combination of midazolam alfentanil and propofol for deep sedation of elderly patients undergoing ercp
topic Endoscopic retrograde cholangiopancreatography
Elderly
Deep sedation
Midazolam
Alfentanil
Propofol
url https://doi.org/10.1186/s12876-024-03197-9
work_keys_str_mv AT yanpingzhang safetyandefficacyofalowdosecombinationofmidazolamalfentanilandpropofolfordeepsedationofelderlypatientsundergoingercp
AT ningzhang safetyandefficacyofalowdosecombinationofmidazolamalfentanilandpropofolfordeepsedationofelderlypatientsundergoingercp
AT jinghu safetyandefficacyofalowdosecombinationofmidazolamalfentanilandpropofolfordeepsedationofelderlypatientsundergoingercp
AT changlinliu safetyandefficacyofalowdosecombinationofmidazolamalfentanilandpropofolfordeepsedationofelderlypatientsundergoingercp
AT guanjunli safetyandefficacyofalowdosecombinationofmidazolamalfentanilandpropofolfordeepsedationofelderlypatientsundergoingercp